AstraZeneca’s campaign supporting its asthma and COPD treatment Breztri features several AI-generated elements.

The Cambridge, England-based pharmaceutical company said the recommendation, from the Committee for Medicinal Products for Human Use of the European Medicines Agency, covers Klygefa as an add-on to ...

AstraZeneca plc (NASDAQ:AZN) is exploring whether one of its biggest cancer drugs can work better with a carefully selected ...

AstraZeneca gets a Buy rating as its core business is still growing while a deep late-stage pipeline gives investors multiple ...

Amgen Inc. (NASDAQ:AMGN) and AstraZeneca PLC (NYSE:AZN) received a positive boost after their combination of Amgen’s ...

The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales ...

Today we feature data from studies being presented at the ongoing European Respiratory Society Congress in Barcelona.

Trastuzumab deruxtecan is a HER2-directed antibody drug conjugate (ADC) discovered by Daiichi Sankyo and jointly developed and commercialized by Daiichi Sankyo and AstraZeneca. The treatment combines ...

The ink was barely dry on the FDA approval letter for AstraZeneca’s Etcamah before the oral SERD suffered a key clinical ...

AstraZeneca AZN announced that the FDA has approved Etcamah (camizestrant) in combination with a medicine belonging to the ...

A UAB researcher is working to establish how artificial intelligence can be used to better understand one of cancer’s ...

Clever Culture Systems is among ASX healthcare companies adopting a successful 'land and expand' strategy for growth.